| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1031557 |
| landingPage: |
http://www.iedb.org/assay/3338766 |
| type: |
Literature
|
| publicationVenue: |
Biomed Pharmacother
|
| dates: |
2017
|
| study type: | t cell assays |
| subject species: | Homo sapiens |
| fullName: |
Zhixin Li
Jinzhi Fang
Rui Jiao
Xiaomin Wei
Yanjie Ma
Xiaoran Liu
Peng Cheng
Taiming Li
|
| method: |
in vivo assay
|
| name: |
A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
|
| description: |
80% of epitope immunized mice survived as compared to 60% of control animals, however, the epitope did not control hyperglycemia.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |